Current Oncology Reports

, Volume 11, Issue 4, pp 255–262 | Cite as

Exercise therapy across the lung cancer continuum

  • Lee W. Jones
  • Neil D. Eves
  • Emily Waner
  • Anil A. Joy
Article

Abstract

A lung cancer diagnosis and associated therapeutic management are associated with unique and varying degrees of adverse physical/functional impairments that dramatically reduce patients’ ability to tolerate exercise. Poor exercise capacity predisposes to increased susceptibility to other common age-related diseases, poor quality of life, and likely premature death. This article reviews the literature investigating the role of exercise as an adjunct therapy across the lung cancer continuum (ie, prevention to palliation). The current evidence suggests that exercise training is a safe and feasible adjunct therapy for patients with operable lung cancer both before and after pulmonary resection. Among patients with inoperable disease, feasibility and safety studies of carefully prescribed exercise training are warranted. Preliminary evidence in this area suggests that exercise therapy may be an important consideration in multidisciplinary management of patients diagnosed with lung cancer.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Jemal A, Siegel R, Ward E, et al.: Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71–96.PubMedCrossRefGoogle Scholar
  2. 2.
    Friedenreich CM, Orenstein MR: Physical activity and cancer prevention: etiologic evidence and biological mechanisms. J Nutr 2002, 132(11 Suppl):3456S–3464S.PubMedGoogle Scholar
  3. 3.
    McTiernan A: Mechanisms linking physical activity with cancer. Nat Rev Cancer 2008, 8:205–211.PubMedCrossRefGoogle Scholar
  4. 4.
    Steindorf K, Friedenreich C, Linseisen J, et al.: Physical activity and lung cancer risk in the European Prospective Investigation into Cancer and Nutrition Cohort. Int J Cancer 2006, 119:2389–2397.PubMedCrossRefGoogle Scholar
  5. 5.
    International Agency for Research on Cancer: IARC Handbooks of Cancer Prevention, vol 6, Weight Control and Physical Activity. Lyon, France: IARC; 2002.Google Scholar
  6. 6.
    Winningham ML, MacVicar MG: The effect of aerobic exercise on patient reports of nausea. Oncol Nurs Forum 1988, 15:447–450.PubMedGoogle Scholar
  7. 7.
    Winningham ML, MacVicar MG, Bondoc M, et al.: Effect of aerobic exercise on body weight and composition in patients with breast cancer on adjuvant chemotherapy. Oncol Nurs Forum 1989, 16:683–689.PubMedGoogle Scholar
  8. 8.
    MacVicar MG, Winningham ML, Nickel JL: Effects of aerobic interval training on cancer patients’ functional capacity. Nurs Res 1989, 38:348–351.PubMedCrossRefGoogle Scholar
  9. 9.
    Winningham ML: Walking program for people with cancer. Getting started. Cancer Nurs 1991, 14:270–276.PubMedCrossRefGoogle Scholar
  10. 10.
    Brown JK, Byers T, Doyle C, et al.: Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices. CA Cancer J Clin 2003, 53:268–291.PubMedCrossRefGoogle Scholar
  11. 11.
    Brown J, Byers T, Thompson K, et al.: Nutrition during and after cancer treatment: a guide for informed choices by cancer survivors. CA Cancer J Clin 2001, 51:153–187; quiz 189–192.PubMedCrossRefGoogle Scholar
  12. 12.
    Jones LW, Demark-Wahnefried W: Diet, exercise, and complementary therapies after primary treatment for cancer. Lancet Oncol 2006, 7:1017–1026.PubMedCrossRefGoogle Scholar
  13. 13.
    McNeely ML, Campbell KL, Rowe BH, et al.: Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis. CMAJ 2006, 175:34–41.PubMedGoogle Scholar
  14. 14.
    Markes M, Brockow T, Resch KL: Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev 2006, CD005001.Google Scholar
  15. 15.
    Schmitz KH, Holtzman J, Courneya KS, et al.: Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005, 14:1588–1595.PubMedCrossRefGoogle Scholar
  16. 16.
    Friendenreich CM, Courneya KS: Exercise as rehabilitation for cancer patients. Clin J Sport Med 1996, 6:237–244.PubMedCrossRefGoogle Scholar
  17. 17.
    Stevinson C, Lawlor DA, Fox KR: Exercise interventions for cancer patients: systematic review of controlled trials. Cancer Causes Control 2004, 15:1035–1056.PubMedCrossRefGoogle Scholar
  18. 18.
    Beckles MA, Spiro SG, Colice GL, Rudd RM: The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003, 123(1 Suppl):105S–114S.PubMedCrossRefGoogle Scholar
  19. 19.
    Beckles MA, Spiro SG, Colice GL, Rudd RM: Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes. Chest 2003, 123(1 Suppl):97S–104S.PubMedCrossRefGoogle Scholar
  20. 20.
    American Thoracic Society; American College of Chest Physicians: ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003, 167:211–277.CrossRefGoogle Scholar
  21. 21.
    Jones LW, Eves ND, Haykowsky M, et al.: Cardiorespiratory exercise testing in clinical oncology research: systematic review and practice recommendations. Lancet Oncol 2008, 9:757–765.PubMedCrossRefGoogle Scholar
  22. 22.
    Myers J, Prakash M, Froelicher V, et al.: Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 2002, 346:793–801.PubMedCrossRefGoogle Scholar
  23. 23.
    Gulati M, Black HR, Shaw LJ, et al.: The prognostic value of a nomogram for exercise capacity in women. N Engl J Med 2005, 353:468–475.PubMedCrossRefGoogle Scholar
  24. 24.
    Gulati M, Pandey DK, Arnsdorf MF, et al.: Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation 2003, 108:1554–1559.PubMedCrossRefGoogle Scholar
  25. 25.
    Bobbio A, Chetta A, Carbognani P, et al.: Changes in pulmonary function test and cardio-pulmonary exercise capacity in COPD patients after lobar pulmonary resection. Eur J Cardiothorac Surg 2005, 28:754–758.PubMedCrossRefGoogle Scholar
  26. 26.
    Wang JS, Abboud RT, Wang LM: Effect of lung resection on exercise capacity and on carbon monoxide diffusing capacity during exercise. Chest 2006, 129:863–872.PubMedCrossRefGoogle Scholar
  27. 27.
    Win T, Jackson A, Groves AM, et al.: Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax 2006, 61:57–60.PubMedCrossRefGoogle Scholar
  28. 28.
    Jones LW, Peddle CJ, Eves ND, et al.: Effects of presurgical exercise training on cardiorespiratory fitness among patients undergoing thoracic surgery for malignant lung lesions. Cancer 2007, 110:590–598.PubMedCrossRefGoogle Scholar
  29. 29.
    Jones LW, Eves ND, Peddle CJ, et al.: Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions. Appl Physiol Nutr Metab 2009, 34:197–202.PubMedCrossRefGoogle Scholar
  30. 30.
    Bobbio A, Chetta A, Ampollini L, et al.: Preoperative pulmonary rehabilitation in patients undergoing lung resection for non-small cell lung cancer. Eur J Cardiothorac Surg 2008, 33:95–98.PubMedCrossRefGoogle Scholar
  31. 31.
    Semik M, Schmid C, Trosch F, et al.: Lung cancer surgery—preoperative risk assessment and patient selection. Lung Cancer 2001, 33(Suppl 1):S9–S15.PubMedCrossRefGoogle Scholar
  32. 32.
    Datta D, Lahiri B: Preoperative evaluation of patients undergoing lung resection surgery. Chest 2003, 123:2096–2103.PubMedCrossRefGoogle Scholar
  33. 33.
    Bolliger CT, Jordan P, Soler M, et al.: Pulmonary function and exercise capacity after lung resection. Eur Respir J 1996, 9:415–421.PubMedCrossRefGoogle Scholar
  34. 34.
    Nagamatsu Y, Maeshiro K, Kimura NY, et al.: Long-term recovery of exercise capacity and pulmonary function after lobectomy. J Thorac Cardiovasc Surg 2007, 134:1273–1278.PubMedCrossRefGoogle Scholar
  35. 35.
    Marks LB, Yu X, Vujaskovic Z, et al.: Radiation-induced lung injury. Semin Radiat Oncol 2003, 13:333–345.PubMedCrossRefGoogle Scholar
  36. 36.
    Bauerle O, Chrusch CA, Younes M: Mechanisms by which COPD affects exercise tolerance. Am J Respir Crit Care Med 1998, 157:57–68.PubMedGoogle Scholar
  37. 37.
    Saltin B, Blomqvist G, Mitchell JH, et al.: Response to exercise after bed rest and after training. Circulation 1968, 38(5 Suppl):VII1–VII78.PubMedGoogle Scholar
  38. 38.
    McGuire DK, Levine BD, Williamson JW, et al.: A 30-year follow-up of the Dallas Bedrest and Training Study: II. Effect of age on cardiovascular adaptation to exercise training. Circulation 2001, 104:1358–1366.PubMedCrossRefGoogle Scholar
  39. 39.
    McGuire DK, Levine BD, Williamson JW, et al.: A 30-year follow-up of the Dallas Bedrest and Training Study: I. Effect of age on the cardiovascular response to exercise. Circulation 2001, 104:1350–1357.PubMedCrossRefGoogle Scholar
  40. 40.
    Jones LW, Eves ND, Haykowsky M, et al.: The physiologic and molecular mechanisms of exercise intolerance and the role of exercise therapy to reverse dysfunction in cancer. Lancet Oncol (in press).Google Scholar
  41. 41.
    Spruit MA, Janssen PP, Willemsen SC, et al.: Exercise capacity before and after an 8-week multidisciplinary inpatient rehabilitation program in lung cancer patients: a pilot study. Lung Cancer 2006, 52:257–260.PubMedCrossRefGoogle Scholar
  42. 42.
    Cesario A, Ferri L, Galetta D, et al.: Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer 2007, 57:118–119.PubMedCrossRefGoogle Scholar
  43. 43.
    Jones LW, Eves ND, Peterson BL, et al.: Safety and feasibility of aerobic training on cardiopulmonary function and quality of life in postsurgical non-small cell lung cancer patients: a pilot study. Cancer 2008, 113:3430–3439.PubMedCrossRefGoogle Scholar
  44. 44.
    Jones LW, Eves ND, Mackey JR, et al.: Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer. Lung Cancer 2007, 55:225–232.PubMedCrossRefGoogle Scholar
  45. 45.
    Lederer DJ, Arcasoy SM, Wilt JS, et al.: Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2006, 174:659–664.PubMedCrossRefGoogle Scholar
  46. 46.
    Maltais F, LeBlanc P, Whittom F, et al.: Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD. Thorax 2000, 55:848–853.PubMedCrossRefGoogle Scholar
  47. 47.
    Maltais F, Sullivan MJ, LeBlanc P, et al.: Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. Eur Respir J 1999, 13:850–854.PubMedCrossRefGoogle Scholar

Copyright information

© Current Medicine Group, LLC 2009

Authors and Affiliations

  • Lee W. Jones
    • 1
  • Neil D. Eves
  • Emily Waner
  • Anil A. Joy
  1. 1.Duke University Medical CenterDurhamUSA

Personalised recommendations